A.G. VASILYEV¹, D.I. ABDULGANIYEVA², А.А. SADRIYEVA², R.G. MUKHINA¹

¹City Clinical Hospital № 7, 54 Chuykov St., 420103 Kazan, Russian Federation

²Kazan State Medical University, 49 Butlerov St., 420012 Kazan, Russian Federation

Vasilyev A.G. — rheumatologist of the City Rheumatology Centre, tel. (843) 237-91-75, e-mail: artem.vasilyev@bk.ru¹

Abdulganiyeva D.I. — D. Med. Sc., Head of the Department of Hospital Therapy with a course in Endocrinology, tel. (843) 261-51-99, e-mail: diana_s@mail.ru²

Sadriyeva A.A. — resident doctor of the Department of Hospital Therapy with a course in Endocrinology, tel. (843) 261-51-99, e-mail: nru07@yandex.ru²

Mukhina R.G. — Head of the Department of Reumatology, tel. (843) 237-91-75, e-mail: artem.vasilyev@bk.ru¹

The article presents the results of study of 52 patients with rheumatoid arthritis. The characteristic of the demographic, clinical and laboratory features of these patients is given The problems of diagnosis of changes in bone mineral density are revealed, as well as their correlation with disease activity, functional status, and laboratory markers of inflammation. The study demonstrated that osteoporosis and osteopenia are quite common in patients with rheumatoid arthritis. Thus, the normal BMD at the lumbar spine (L1-L4) was observed in 8 (15.4%) patients, osteopenia — in 29 (55.8%) and OP — in 15 (28.8%) patients. Normal BMD at the proximal femur was observed in 15 (28.8%) patients, osteopenia — in 24 (46.2%) and OP — in 13 (25.0%) patients. Reduced BMD correlated with rheumatoid arthritis activity, decreased functional status, disease duration and corticosteroids intake. In addition, a high risk of falling in patients with decreased BMD at the lumbar spine and proximal femur was revealed.

Key words: bone mineral density, osteoporosis, osteopenia, rheumatoid arthritis, falling.

 

 

REFERENCES

1. Nasonov E.L. Pharmacotherapy of rheumatoid arthritis from the perspective of evidence based medicine: new recommendations. Russkiy meditsinskiy zhurnal, 2002, no. 6 (in Russ.).

2. Nasonov E.L. Protivovospalitel’naya terapiya revmaticheskikh bolezney [Anti-inflammatory therapy of rheumatic diseases]. Moscow, M-SITI, 1996. 345 p.

3. Weitzmann M.N., Pacifici R. The role of T lymphocytes in bone metabolism. Immunol Rev., 2005, vol. 208, r. 154-68.

4. Crotti T.N., Smith M.D., Weedon H. et al. Receptor activator NF-kappa-B ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: semiquantitative and quantitative analysis. Ann Rheum Dis., 2002, vol. 61, r. 1047-54.

5. Gough A.K., Lilley J., Eyre S., Holder R.L., Emery P. Generalised bone loss inpatients with early rheumatoid arthritis. Lancet, 1994, vol. 344, r. 23-7.

6. Sambrook P.N., Spector T.D., Seeman E., Bellamy N., Buchanan R.R., Duffy D.L. et al. Osteoporosis in rheumatoid arthritis. A monozygotic co-twin control study. Arthritis Rheum., 1995, vol. 38, r. 806-9.

7. Spector T.D., Hall G.M., McCloskey E.V., Kanis J.A. Risk of vertebral fracture in women with rheumatoid arthritis. BMJ, 1993, vol. 306, r. 558.

8. Huusko T.M., Korpela M., Karppi P., Avikainen V., Kautiainen H., Sulkava R. Threefold increased risk of hip fractures with rheumatoid arthritis in Central Finland. Ann Rheum Dis., 2001, vol. 60, r. 521-2.

9. Cooper C., Coupland C., Mitchell M. Rheumatoid arthritis, corticosteroidtherapy and hip fracture. Ann Rheum Dis., 1995, vol. 54, r. 49-52.

10. Lodder M.C., Haugeberg G., Lems W.F., Uhlig T., Orstavik R.E., Kostense P. et al. Radiological damage is associated with low BMD and vertebral deformities inrheumatoid arthritis. The Oslo-Truro-Amsterdam (OSTRA) collaborative study. Arthritis Rheum Arthritis Care Res., 2003, vol. 49, r. 209-15.

11. Haugeberg G., Uhlig T., Falch J.A., Halse J.I., Kvien T.K. Bone mineral density andfrequency of osteoporosis in female patients with rheumatoid arthritis: resultsfrom 394 patients in the Oslo County Rheumatoid Arthritis register. Arthritis Rheum., 2000, vol. 43, r. 522-30.

12. Haugeberg G., Uhlig T., Falch J.A., Halse J.I., Kvien T.K. Reduced bone mineral density in male rheumatoid arthritis patients: frequencies and associations with demographic and disease variables in ninety-four patients in the Oslo County Rheumatoid Arthritis Register. Arthritis Rheum., 2000, vol. 43, r. 2776-84.

13. Lems W.F., Dijkmans B.A. Should we look for osteoporosis in patients with rheumatoid arthritis? Ann Rheum Dis., 1998, vol. 57, r. 325-7.

14. Hall G.M., Spector T.D., Griffin A.J., Jawad A.S., Hall M.L., Doyle D.V. The effect of rheumatoid arthritis and steroid therapy on bone density in postmenopausal women. Arthritis Rheum., 1993, vol. 36, r. 1510-16.

15. Orstavik R.E., Haugeberg G., Mowinckel et al. Vertebral deformities in rheumatoid arthritis: a comparison with population based controls. Arch Intern Med., 2004, vol. 164, r. 420-425.

16. de Nijs R.N., Jacobs J.W., Bijlsma J.W. et al. Prevalence of vertebral deformities and symptomatic vertebral fractures in corticosteroid treated patients with rheumatoid arthritis. Rheumatology (Oxford), 2001, vol. 40, r. 1375-1383.

17. Peel N.F., Moore D.J., Barrington N.A. et al. Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. Ann Rheum Dis., 1995, vol. 54, r. 801-806.

18. Hooyman J.R., Melton L.J., Nelson A.M., O’Fallon W.M., Riggs B.L. Fractures after rheumatoid arthritis. A population based study. Arthritis Rheum., 1984, vol. 27, r. 1353-61.

19. Cummings S., Nevitt M., Browner W., Stone K., Fox K., Ensrud K., Cauley J., Black D., Vogt T. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med., 1995, vol. 332, r. 767-773.

20. Dargent-Molina P., Favier F., Grandjean H., Baudoin C., Schott A., Hausherr E., Meunier P., Bréart G.: Fall-related factors and risk of hip fracture: the EPIDOS prospective study. Lancet, 1996, vol. 348, r. 145-149.

21. Durward G., Non Pugh C., Ogunremi L., Wills R., Cottee M., Patel S. Detection of risk of falling and hip fracture in women referred for bone densitometry. Lancet, 1999, vol. 354, r. 220-221.

22. Leveille S., Jones R., Kiely D., Hausdorff J., Shmerling R., Guralnik J., Kiel D., Lipsitz L., Bean J. Chronic musculoskeletal pain and the occurrence off alls in an older population. JAMA, 2009, vol. 302, r. 2214-2221.

23. Armstrong C., Swarbrick C.M., Pye S.R., O’Neill T.W. Occurrence and risk factors for falls in rheumatoid arthritis. Ann Rheum Dis., 2005, vol. 64, r. 1602-4.

24. Fessel K.D., Nevitt M.C. Correlates of fear of falling and activity limitation among persons with rheumatoid arthritis. Arthritis Care Res., 1997, vol. 10, r. 222-8.

25. The World Health Organization (2007) Assessment of osteoporosis at the primary health care level — Summary report of a WHO Scientific Group. WHO, Geneva.

26. Binkley N., Bilezikian J.P., Kendler D.L. et al. Summary of the international society for clinical densitometry 2005 position development conference. J Bone Miner Res., 2007, vol. 22, r. 643.